107 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Rapport financier semestriel 2011 (french) > Rapport d’activité semestriel 2011 |
Half Year Report | ||
2011 Half Year Results 2011 Half year results |
Half Year Report | ||
Vétoquinol continues to develop its product ranges and enters the brazilian market Lure (France), August 30, 2011 – The Vetoquinol Board Meeting of August 29, 2011 reviewed the Group’s business and approved the financial statements for the first half 2011. |
Public releases | ||
Procès-verbal des délibérations de l'assemblée générale mixte du 20 mai 2011 |
Shareholders´s Meeting | ||
International expansion and new product launches Lure (France), July 19, 2011 – Vétoquinol Group sales rose to €139.7 million in the first six months of 2011. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - June 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
Voting rights | ||
Programme de rachat - juin 2011(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Monthly communication regarding buyback programs | ||
Arrêté de la feuille de présence (french) |
Shareholders´s Meeting | ||
European launch of new Nsaid Cimalgex® Lure (France), June 14, 2011 – Vetoquinol announces the European launch of CIMALGEX®, a new treatment for pain and inflammation in dogs. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - May 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
Voting rights |